Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 24,000 shares at $18.92 ($449K) on 2020-10-02, disclosed to the SEC on 2020-10-05.
Open-market sale of $449k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.84 | 8,000 | $151K | 33.6% |
| 2 | $18.92 | 8,000 | $151K | 33.7% |
| 3 | $18.35 | 8,000 | $147K | 32.7% |
| Total | $18.70 avg | 24,000 | $449K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |